Location: PRINCETON, NJ
CIK: 0001907884 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $1.621B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| URGN | UROGEN PHARMA LTD | 2,247,393 | $40.41M | 2.5% | — | — | COM | M96088105 |
| LEGN | LEGEND BIOTECH CORP | 1,576,295 | $28.52M | 1.8% | — | — | SPONSORED ADS | 52490G102 |
| TVTX | TRAVERE THERAPEUTICS INC | 800,000 | $23.77M | 1.5% | — | — | CALL | 89422G107 |
| RVMD | REVOLUTION MEDICINES INC | 207,500 | $20.18M | 1.2% | — | — | PUT | 76155X100 |
| SLNO | SOLENO THERAPEUTICS INC | 560,000 | $18.75M | 1.2% | — | — | COM | 834203309 |
| TVTX | TRAVERE THERAPEUTICS INC | 54,900 | $1.631M | 0.1% | — | — | PUT | 89422G107 |
| CADL | CANDEL THERAPEUTICS INC | 200,000 | $980K | 0.1% | — | — | COM | 137404109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CTMX | CYTOMX THERAPEUTICS INC. | 15,013,093 (+67.4%) | $70.56M (+84.7%) | 4.4% | — | — | COM | 23284F105 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,569,018 (+203.0%) | $46.62M (+135.6%) | 2.9% | — | — | COM | 89422G107 |
| BEAM | BEAM THERAPEUTICS INC | 3,682,185 (+50.9%) | $87.75M (+29.7%) | 5.4% | — | — | COM | 07373V105 |
| STRO | SUTRO BIOPHARMA INC | 872,558 (+81.9%) | $21.74M (+291.7%) | 1.3% | — | — | COM SHS | 869367201 |
| EVMN | EVOMMUNE INC | 625,496 (+237.2%) | $14.38M (+352.9%) | 0.9% | — | — | COM SHS | 30054Y107 |
| GERN | GERON CORP | 6,836,318 (+97.8%) | $10.19M (+123.3%) | 0.6% | — | — | COM | 374163103 |
| PRLD | PRELUDE THERAPEUTICS INC | 1,592,551 (+101.9%) | $5.447M (+138.1%) | 0.3% | — | — | COM | 74065P101 |
| IMCR | IMMUNOCORE HLDGS PLC | 884,937 (+3.3%) | $26.68M (-10.2%) | 1.6% | — | — | ADS | 45258D105 |
| AMRN | AMARIN CORP PLC | 472,382 (+21.3%) | $6.831M (+25.7%) | 0.4% | — | — | SPONSORED ADR | 023111404 |
| BNR | BURNING ROCK BIOTECH LTD | 1,227,555 (+23.4%) | $19.79M (-1.3%) | 1.2% | — | — | SPONSORED ADS | 12233L206 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,341,652 (+59.2%) | $45.8M (+0.1%) | 2.8% | — | — | COM | 92790C104 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TYRA | TYRA BIOSCIENCES INC | 1,564,492 | $41.13M | 2.5% | — | — | — | 90240B106 |
| CGON | CG ONCOLOGY INC | 945,830 | $39.27M | 2.4% | — | — | — | 156944100 |
| BEAM | BEAM THERAPEUTICS INC | 937,000 | $25.97M | 1.6% | — | — | CALL | 07373V105 |
| — | DYNAVAX TECHNOLOGIES CORP | 1,375,632 | $21.16M | 1.3% | — | — | — | 268158201 |
| OMER | OMEROS CORP | 200,000 | $3.436M | 0.2% | — | — | PUT | 682143102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 4,037,331 (-34.5%) | $155M (-29.0%) | 9.6% | — | — | COM | 19240Q201 |
| VERA | VERA THERAPEUTICS INC | 3,398,224 (-1.0%) | $137M (-21.4%) | 8.4% | — | — | CL A | 92337R101 |
| WVE | WAVE LIFE SCIENCES LTD | 965,193 (-55.5%) | $6.998M (-81.0%) | 0.4% | — | — | SHS | Y95308105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 5,840,567 (-1.7%) | $185M (+14.8%) | 11.4% | — | — | COM NEW | 15117B202 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 5,680,795 (-39.4%) | $54.08M (-26.0%) | 3.3% | — | — | COM | 09058V103 |
| NRIX | NURIX THERAPEUTICS INC | 1,194,757 (-39.4%) | $18.52M (-50.5%) | 1.1% | — | — | COM | 67080M103 |
| APLS | APELLIS PHARMACEUTICALS INC | 825,000 (-9.2%) | $33.19M (+45.4%) | 2.0% | — | — | COM | 03753U106 |
| ENGN | ENGENE HOLDINGS INC | 1,356,843 (-9.1%) | $9.24M (-31.5%) | 0.6% | — | — | COM | 29286M105 |
| CLYM | CLIMB BIO INC | 1,003,341 (-2.4%) | $6.873M (+67.1%) | 0.4% | — | — | COM | 28658R106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCVX | VAXCYTE INC | 2,922,335 | $170M | 10.5% | — | — | COM | 92243G108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 8,050,959 | $188M | 11.6% | — | — | COM | 87164F105 |
| CGEM | CULLINAN THERAPEUTICS INC | 3,114,132 | $44.25M | 2.7% | — | — | COM | 230031106 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,820,954 | $36.66M | 2.3% | — | — | COM | 483497103 |
| RLAY | RELAY THERAPEUTICS INC | 1,424,259 | $14.17M | 0.9% | — | — | COM | 75943R102 |
| BHVN | BIOHAVEN LTD | 702,884 | $5.946M | 0.4% | — | — | COM | G1110E107 |
| MBX | MBX BIOSCIENCES INC | 934,799 | $27.9M | 1.7% | — | — | COM | 55287L101 |
| ALEC | ALECTOR INC | 2,000,000 | $4.3M | 0.3% | — | — | COM | 014442107 |
| DSGN | DESIGN THERAPEUTICS INC | 784,606 | $8.348M | 0.5% | — | — | COM | 25056L103 |
| CRBU | CARIBOU BIOSCIENCES INC | 2,503,302 | $4.756M | 0.3% | — | — | COM | 142038108 |
| PRQR | PROQR THRAPEUTICS N V | 1,566,317 | $2.537M | 0.2% | — | — | SHS EURO | N71542109 |
| PHVS | PHARVARIS N V | 640,395 | $18.09M | 1.1% | — | — | COM | N69605108 |